- Home
- NAAS vs OSRH Comparison
NAAS vs OSRH Comparison
Compare NAAS & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NAAS | OSRH |
|---|---|---|
| Founded | 2019 | N/A |
| Country | China | United States |
| Employees | N/A | 21 |
| Industry | Other Specialty Stores | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.4M | 11.7M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | NAAS | OSRH |
|---|---|---|
| Price | $2.48 | $0.55 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.3K | ★ 810.2K |
| Earning Date | 04-28-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $378.49 | $9.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.41 | $0.38 |
| 52 Week High | $4.54 | $1.79 |
Technical Indicators
Market Signals| Indicator | NAAS | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 49.33 | 58.19 |
| Support Level | $2.23 | $0.55 |
| Resistance Level | $2.70 | $0.60 |
| Average True Range (ATR) | 0.20 | 0.07 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 33.12 | 66.11 |
Price Performance
Historical ComparisonAbout NAAS NaaS Technology Inc.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators, a wide range of offline services that simplify the daily operations of charging station operators, and non-charging services such as food and beverage services to station operators.
About OSRH OSR Holdings Inc.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.